August 29, 2023 Externally-Led Patient Focused Drug Development C-Path’s Polycystic Kidney Disease Outcomes Consortium (PKDOC) and the PKD Foundation will be hosting an Externally-Led Patient
August 25, 2023 C-Path’s Romero Appears on The BioCentury Show Klaus Romero, Chief Science Officer at Critical Path Institute, occupies a rare role in the industry, as the top scientist in an o
August 25, 2023 C-Path is pleased to welcome Acurex Biosciences as the newest member joining its Critical Path for Parkinson’s Consortium AcureX is a pharmaceutical company on a mission to stop major neurodegenerative diseases before they start, with an
August 25, 2023 C-Path’s Role in IHI Call 4: Enhancing Rare Disease Clinical Trials This memo outlines how C-Path can contribute as a key strategic regulatory partner to the Innovative Health Initiative’s (I
August 22, 2023 C-Path Welcomes ObvioHealth C-Path is proud to welcome ObvioHealth, a virtual research organization (VRO), as the newest member of its Electro
August 21, 2023 Postdoc Ruby Abrams Shares Professional Development Opportunities Provided by C-Path Critical Path Institute is dedicated to advancing careers in the medical development and regulatory science industries. We are hap
August 17, 2023 C-Path to Host a Scientific Breakthrough Summit Oct. 26-27 Addressing Unmet Regulatory Needs and Drug Development Opportunities through Collaborations in Type 1 Diabetes, Alpha-1 Antitrypsi
August 15, 2023 NORDs’ IAMRARE Registry Contributes Two New Datasets to C-Path’s RDCA-DAP, Boosting Rare Disease Research and Therapeutic Advancement TUCSON, Ariz., August 15, 2023 — Critical Path Institute (C-Path) announced today that the National Organization for Rare Disord
August 10, 2023 View Now: Teaching Patients and Caregivers: The Role of Education in Research and Data Sharing Thursday, August 10, noon ET: This webinar will focus on the role of foundational education in research concepts, such as data lit
August 9, 2023 C-Path’s Duchenne Regulatory Science Consortium and Duchenne Data Foundation Announce Collaboration to Advance Solutions for Duchenne Muscular Dystrophy C-Path's Duchenne Regulatory Science Consortium (D-RSC) and the Duchenne Data Foundation (DDF) are excited to announce...
